Aussie vet tech firm Vedi secures $3 million investment

The Perth-based company intends to expand the “first-of-its-kind” medical record technology for pets in Australia and into the UK with the recent investment from Companion Fund, pharma company Merck & Co’s MSD Animal Health, and pet care investment firm.

“Vedi is a promising technology that could expedite a new digital age of veterinary care,” Companion Fund said.

The company claims to usher in a new age of digital veterinary care with its comprehensive medical record program and smart data collection tools. The system created for pets will enable vets to view hospital notes and clinical documents online.

Veterinary specialists can access, share, and update that information across the pet’s lifetime using the Vedi platform. Additionally, the company said vets could register a microchip, record vaccinations, or submit pathology work in seconds.

Improving data accessibility

Dr. Steve Joslyn, CEO of Vedi and Specialty Radiologist, said, “Vedi is radically improving the quality and accessibility of veterinary health data and creating a smarter, connected healthcare system. We’ve taken it upon ourselves to become the trusted medical record that connects different veterinary providers so animals can access the best quality care anytime, anywhere.”

In the long term, Dr. Joslyn notes that the prospects of Vedi are even more “exciting.” He believes that accumulating improved quality health data over a pet’s lifetime will open the doors to research opportunities, biosecurity programs, and innovative lifesaving treatments.

“Vedi means that soon animals and vets will have a better connected, streamlined healthcare system than the human world.”